Today: 21 May 2026
Lam Research stock slips after-hours even as Cantor lifts target to $265
9 January 2026
1 min read

Lam Research stock slips after-hours even as Cantor lifts target to $265

New York, Jan 8, 2026, 19:16 EST — After-hours

Lam Research Corp (LRCX.O) shares slipped nearly 1%, closing at $200.96 in after-hours trading on Thursday, caught up in a wider decline among chipmakers. Applied Materials (AMAT.O) took a bigger hit, tumbling 3.6%, while KLA (KLAC.O) dropped 2.6%. Meanwhile, the VanEck Semiconductor ETF (SMH) slid roughly 1.6%.

Cantor Fitzgerald bumped up its price target on Lam to $265 from $210, keeping an “Overweight” rating in place. The firm says the next surge in wafer fabrication equipment spending is still on the horizon. Analyst C.J. Muse wrote, “Conviction remains high,” supporting an “All-In” approach on the chip-tool sector; wafer fabrication equipment, or WFE, refers to the machines that produce chips. TipRanks

The timing is crucial since chip-equipment stocks often act as a high-beta segment of U.S. tech, reacting sharply to changes in risk appetite. U.S. stock indexes dipped on Thursday, pulled down by major tech players, while investors awaited Friday’s nonfarm payrolls report for hints on where interest rates might head.

Lam has dropped for two days in a row, closing roughly 4.5% under its 52-week peak of $210.45, according to MarketWatch data. After the recent surge, traders are now eyeing whether it can stay above the $200 mark ahead of the next big move.

For Lam, the immediate concern isn’t the daily tape but what customers reveal about capital spending — the budgets chipmakers allocate for new equipment and factory overhauls. Shifts in orders and the speed of memory and logic investment usually surface first in toolmaker reports.

But the setup works both ways. A stronger-than-expected U.S. jobs report can swiftly shift rate expectations and weigh on high-multiple tech stocks, while even a small sign that chipmakers are holding back on spending can drag down equipment shares, which have already factored in a lengthy growth cycle.

Lam said it will hold its December-quarter financial conference call and webcast on Jan. 28 at 2 p.m. PST (5 p.m. EST). That’s the next event investors will watch closely to weigh the bull case.

Stock Market Today

  • Nifty 50 and Sensex Expected to Open Higher on May 21 Amid US-Iran Ceasefire Hopes
    May 20, 2026, 10:38 PM EDT. Indian stock indices Sensex and Nifty 50 are poised for a positive start on May 21, following global market gains and optimism over a US-Iran ceasefire deal. The Sensex gained 117.54 points to close at 75,318.39 and Nifty 50 rose 41 points to 23,659 on May 20. Technical analysts highlight a sideways trading range with key Sensex support at 74,500 and resistance near 76,000. Nifty 50 shows bullish candlestick patterns, suggesting buying strength near lower levels and a breakout above 23,800 could trigger further gains. Derivatives data show call and put writing aligning with these support and resistance zones, indicating cautious but optimistic market sentiment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Sandisk (SNDK) stock drops after CES-fueled surge cools, with earnings next
Previous Story

Sandisk (SNDK) stock drops after CES-fueled surge cools, with earnings next

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls
Next Story

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

Go toTop